Compare IRS & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
Current Price
Current Price
| Metric | IRS | NEO |
|---|---|---|
| Founded | 1943 | 2001 |
| Country | Argentina | United States |
| Employees | 1392 | N/A |
| Industry | Homebuilding | Precision Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | N/A | 2008 |
| Metric | IRS | NEO |
|---|---|---|
| Price | $16.65 | $11.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $13.38 |
| AVG Volume (30 Days) | 172.1K | ★ 2.2M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | ★ 9.85% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $10.63 |
| Revenue Next Year | N/A | $9.73 |
| P/E Ratio | $3.66 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.87 | $4.72 |
| 52 Week High | $19.14 | $13.74 |
| Indicator | IRS | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 59.45 | 61.11 |
| Support Level | $16.12 | $7.50 |
| Resistance Level | $17.17 | $11.62 |
| Average True Range (ATR) | 0.81 | 0.63 |
| MACD | 0.15 | -0.06 |
| Stochastic Oscillator | 71.28 | 64.06 |
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segments include Shopping Malls, which comprise lease and service revenues principally related to the rental of commercial and other spaces in the company's shopping malls; Offices, which include lease revenues and other service revenues related to office activities; Sales and Developments, which include the development, maintenance, and sales of undeveloped parcels of land and/or trading properties; Hotels, which mainly include revenues from rooms, catering, and restaurants; and others. The company generates the majority of its revenue from the Shopping Malls segment.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.